Miriam J. Paramore's Insider Trades & SAST Disclosures

Miriam J. Paramore's most recent trade in OptimizeRx Corp was a trade of 15,000 Common Stock Pursuant to 10B5-1 Plan done at an average price of $95.5 . Disclosure was reported to the exchange on Nov. 2, 2021.

Share

Note

This is a custom search result for pattern Miriam J. Paramore.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
OptimizeRx Corp	Miriam J. Paramore	PRES. & CHIEF STRATEGY OFFICER	Sale of securities on an exchange or to another person at price $ 95.45 per share.	02 Nov 2021	15,000	74,607 (0%)	0%	95.5	1,431,750	Common Stock Pursuant to 10B5-1 Plan
OptimizeRx Corp	Miriam J. Paramore	PRES. & CHIEF STRATEGY OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Nov 2021	15,000	94,318	-		-	Stock Option
OptimizeRx Corp	Miriam J. Paramore	PRES. & CHIEF STRATEGY OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share.	02 Nov 2021	15,000	89,607 (0%)	0%	7.5	112,650	Common Stock
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Oct 2021	15,000	109,318	-		-	Stock Option
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Sale of securities on an exchange or to another person at price $ 84.67 per share.	04 Oct 2021	15,000	74,607 (0%)	0%	84.7	1,270,050	Common Stock Pursuant to 10B5-1 Plan
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share.	04 Oct 2021	15,000	89,607 (0%)	0%	7.5	112,650	Common Stock
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share.	02 Sep 2021	15,000	89,607 (0%)	0%	7.5	112,650	Common Stock
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Sep 2021	15,000	124,318	-		-	Stock Option
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Sale of securities on an exchange or to another person at price $ 68.39 per share.	02 Sep 2021	15,000	74,607 (0%)	0%	68.4	1,025,850	Common Stock Pursuant to 10B5-1 Plan
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share.	02 Aug 2021	15,000	89,607 (0%)	0%	7.5	112,650	Common Stock
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Aug 2021	15,000	139,318	-		-	Stock Option
OptimizeRx Corp	Miriam J. Paramore	PRESIDENT AND CSO	Sale of securities on an exchange or to another person at price $ 55.76 per share.	02 Aug 2021	15,000	74,607 (0%)	0%	55.8	836,400	Common Stock Pursuant to 10B5-1 Plan

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades